<?xml version="1.0" encoding="UTF-8"?>
<ref id="B90-vaccines-08-00531">
 <label>90.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Neilan</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Zsak</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Burrage</surname>
    <given-names>T.G.</given-names>
   </name>
   <name>
    <surname>Kutish</surname>
    <given-names>G.F.</given-names>
   </name>
   <name>
    <surname>Rock</surname>
    <given-names>D.L.</given-names>
   </name>
  </person-group>
  <article-title>Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection</article-title>
  <source>Virology</source>
  <year>2004</year>
  <volume>319</volume>
  <fpage>337</fpage>
  <lpage>342</lpage>
  <pub-id pub-id-type="doi">10.1016/j.virol.2003.11.011</pub-id>
  <?supplied-pmid 14980493?>
  <pub-id pub-id-type="pmid">14980493</pub-id>
 </element-citation>
</ref>
